This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| Foley Mark J | 765,761 | 0 |
| Rankin Aubrey Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009 | 321,611 | 0 |
| Rankin Aubrey The Rankin Irrevocable Trust | 154,302 | 0 |
| Browne L Daniel | 151,193 | 0 |
| Joshi Abhay | 120,708 | 0 |
| Sjuts Dustin S | 97,123 | 0 |
| Zavodnick Todd Erik | 96,407 | 0 |
| Rankin Aubrey | 94,091 | 0 |
| SILVERNAIL LAUREN P | 65,497 | 0 |
| Schilke Tobin | 62,525 | 0 |
| Moxie Dwight | 42,694 | 0 |
| Bertolino Arthur Peter | 34,001 | 0 |
| Waugh Jacob | 28,413 | 0 |
| Russell Angus C. | 26,913 | 0 |
| Ruegg Curtis | 23,944 | 0 |
| McDowell Caryn Gordon | 23,453 | 0 |
| Allouche Cyril | 6,400 | 0 |
| Vickers Philip J. | 6,150 | 0 |
| GARDNER PHYLLIS | 3,000 | 0 |
| BYRNES ROBERT F By The Byrnes Family Trust | 0 | 0 |
| ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP By affiliate | 0 | 0 |
| ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP by Essex Woodlands Health Ventures Fund VIII-B, L.P. | 0 | 0 |
| Glasheen James Walter by Technology Partners Fund VII, L.P. | 0 | 0 |
| Tunnicliffe Jonathan by NovaQuest Pharma Opportunities Fund III, L.P. | 0 | 0 |
| Kolaja Carey OConnor | 0 | 0 |
| Browne L Daniel by The Dan and Brenda Browne Living Trust | 0 | 0 |
| 0 | 0 | |
| Eastman Ronald W by Essex Woodlands Health Ventures Fund VIII-A, L.P. | 0 | 0 |
| Eastman Ronald W by Essex Woodlands Health Ventures Fund VIII-B, L.P. | 0 | 0 |
| BYRNES ROBERT F | 0 | 0 |
| ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP by Essex Woodlands Health Ventures Fund VIII-A, L.P. | 0 | 0 |
| WOOTEN RONALD J by NovaQuest Pharma Opportunities Fund III, L.P. | 0 | 0 |
| Ware Olivia C | 0 | 0 |
| Nolet Chris | 0 | 0 |
| WOOTEN RONALD J | 0 | 0 |
| Glasheen James Walter by Technology Partners Affiliates VII, L.P. | 0 | 0 |
| Tunnicliffe Jonathan | 0 | 0 |
| Rankin Aubrey Rankin Family Foundation | 0 | 0 |
| Eastman Ronald W by Essex Woodlands Health Ventures Fund VIII, L.P. | 0 | 0 |
| NovaQuest Pharma Opportunities Fund III, L.P. By affiliate | 0 | 0 |
| GARDNER PHYLLIS by Essex Woodlands Health Ventures Fund V, L.P. | 0 | 0 |
| NovaQuest Pharma Opportunities Fund III, L.P. by NovaQuest Pharma Opportunities Fund III, L.P. | 0 | 0 |
| PRYGOCKI MARK A SR | 0 | 0 |
| Beraud Jill | 0 | 0 |
| Glasheen James Walter | 0 | 0 |
| Gangolli Julian S | 0 | 0 |
| GARDNER PHYLLIS by Essex Woodlands Health Ventures Fund V, L.P. | 0 | 0 |
| Eastman Ronald W | 0 | 0 |
| ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP by Essex Woodlands Health Ventures Fund VIII, L.P. | 0 | 0 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|